Andreas Halvorsen - Viking Global Investors
Holding/activity history for Talaris Therapeutics Inc (TALS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2023 Q1 | 3,289,617 | 0.03 | $1.88 | $6,184,480 | SEC | ||
| 2022 Q4 | 3,289,617 | 0.02 | $1.02 | $3,355,409 | SEC | ||
| 2022 Q3 | 3,289,617 | 0.04 | $2.63 | $8,652,000 | SEC | ||
| 2022 Q2 | 3,289,617 | 0.07 | $4.51 | $14,836,000 | SEC | ||
| 2022 Q1 | 3,289,617 | 0.13 | $9.84 | $32,370,000 | SEC | ||
| 2021 Q4 | 3,289,617 | 0.15 | $15.29 | $50,298,000 | SEC | ||
| 2021 Q3 | 3,289,617 | 0.12 | $13.56 | $44,607,000 | SEC | ||
| 2021 Q2 | 3,289,617 | 0.15 | Buy | 0.15 | $14.69 | $48,324,000 | SEC |